BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2843746)

  • 1. Smoking-related alterations in epidermal growth factor and insulin receptors in human placenta.
    Wang SL; Lucier GW; Everson RB; Sunahara GI; Shiverick KT
    Mol Pharmacol; 1988 Sep; 34(3):265-71. PubMed ID: 2843746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzo(a)pyrene inhibits epidermal growth factor binding and receptor autophosphorylation in human placental cell cultures.
    Guyda HJ; Mathieu L; Lai W; Manchester D; Wang SL; Ogilvie S; Shiverick KT
    Mol Pharmacol; 1990 Feb; 37(2):137-43. PubMed ID: 2154666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of beta-naphthoflavone on insulin receptor binding and protein kinase activity in rat liver and placenta.
    Wang SL; Raizada MK; Shiverick KT
    Mol Pharmacol; 1988 Mar; 33(3):250-6. PubMed ID: 2832720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor-receptor-protein kinase interactions.
    Cohen S; Carpenter G; King L
    Prog Clin Biol Res; 1981; 66 Pt A():557-67. PubMed ID: 6273929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased human birth weights after in utero exposure to PCBs and PCDFs are associated with decreased placental EGF-stimulated receptor autophosphorylation capacity.
    Sunahara GI; Nelson KG; Wong TK; Lucier GW
    Mol Pharmacol; 1987 Nov; 32(5):572-8. PubMed ID: 3119985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F; Goldstein BJ
    J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of human placental epidermal growth factor receptor in intrauterine growth retardation.
    Fondacci C; Alsat E; Gabriel R; Blot P; Nessmann C; Evain-Brion D
    J Clin Invest; 1994 Mar; 93(3):1149-55. PubMed ID: 8132754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
    Gardner DP; Shimizu N
    J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogeny of insulin-like growth factor I and insulin receptor kinase activity in rat liver.
    Menon RK; Chernausek SD; Sperling MA
    J Dev Physiol; 1991 Aug; 16(2):87-97. PubMed ID: 1664842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites.
    Soler C; Alvarez CV; Beguinot L; Carpenter G
    Oncogene; 1994 Aug; 9(8):2207-15. PubMed ID: 8036006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and epidermal growth factor receptors in rat liver after administration of the hepatocarcinogen 2-acetylaminofluorene: ligand binding and autophosphorylation.
    Hwang DL; Roitman A; Carr BI; Barseghian G; Lev-Ran A
    Cancer Res; 1986 Apr; 46(4 Pt 2):1955-9. PubMed ID: 3004714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors for insulin and epidermal growth factor: interaction with organomercurial agarose.
    Aglio LS; Maturo JM; Hollenberg MD
    J Cell Biochem; 1985; 28(2):143-57. PubMed ID: 3001106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the epidermal growth factor receptor by phosphorylation.
    Bertics PJ; Weber W; Cochet C; Gill GN
    J Cell Biochem; 1985; 29(3):195-208. PubMed ID: 3001110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of an insulin-stimulated insulin receptor serine kinase.
    Carter WG; Sullivan AC; Asamoah KA; Sale GJ
    Biochemistry; 1996 Nov; 35(45):14340-51. PubMed ID: 8916921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells.
    Zhong H; Minneman KP
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):889-94. PubMed ID: 10585878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
    Brunton VG; Carlin S; Workman P
    Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.
    Liu SM; Carpenter G
    J Cell Physiol; 1993 Nov; 157(2):237-42. PubMed ID: 7901224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of two-dimensional gel analysis to identification and characterization of tyrosine phosphorylated substrates for growth factor receptors.
    Hansen K; Møller JV
    Electrophoresis; 1993; 14(1-2):112-26. PubMed ID: 7681772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogeny of growth factor receptors in the human placenta.
    Deal CL; Guyda HJ; Lai WH; Posner BI
    Pediatr Res; 1982 Oct; 16(10):820-6. PubMed ID: 6292814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new monoclonal antibody for detection of EGF-receptors in western blots and paraffin-embedded tissue sections.
    Fernandez A; Spitzer E; Perez R; Boehmer FD; Eckert K; Zschiesche W; Grosse R
    J Cell Biochem; 1992 Jun; 49(2):157-65. PubMed ID: 1400622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.